Cannabinoid Mechanisms in Parkinson’s Disease Explained
Recent peer-reviewed research reveals complex mechanisms of cannabinoid action in Parkinson’s disease (PD). The endocannabinoid system (ECS) plays a crucial role in modulating basal ganglia function and PD progression through multiple pathways. Receptor Mechanisms The ECS primarily operates through CB1 and CB2 receptors, with CB1 receptors being particularly abundant in the basal ganglia, cortex, cerebellum,…